AMD outcomes important for patients- Delphi study
Research type
Research Study
Full title
AMD outcomes important for patients- Delphi study Development of core outcome measures for AMD interventions
IRAS ID
191342
Contact name
Augusto/AAB Azuara-Blanco
Contact email
Sponsor organisation
Queen's University Belfast
Duration of Study in the UK
0 years, 10 months, 29 days
Research summary
Randomised controlled trials (RCTs) provide information on effectiveness of new treatments for medical conditions (e.g. for age-related macular degeneration (AMD)) measuring different outcomes. To improve design of trials for a condition, a selection of a group of standard outcomes known as a core outcome set (COS), would be helpful. Our efforts focus around a COS for AMD RCTs. To choose the most appropriate elements for a COS, opinions of key stakeholders (patients, carers and experts) need to be gathered. Thus, in our current study, we would like to achieve consensus among patients regarding the importance and acceptability of different eye tests’ measures and patient-reported outcomes. We aim to conduct 2-3 consecutive questionnaires with feedback for participants between rounds. Surveys will be administered in a timely way giving 4 weeks for participants to respond. Our plan is to recruit 200 AMD patients with impaired vision via the Macular Society research database. The Macular Society will identify potential participants, but it will be up to them if they would like to take part in our study or not. The surveys will be either online (Survey Monkey link emailed to the participants, participants redirected to the survey- Survey Monkey complies with the rules of accessibility for people with impaired vision ) or postal based, depending on preferences of a particular individual.
REC name
West Midlands - Coventry & Warwickshire Research Ethics Committee
REC reference
15/WM/0451
Date of REC Opinion
14 Dec 2015
REC opinion
Further Information Favourable Opinion